DE2258668C3 - Neue Prostaglandine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel - Google Patents

Neue Prostaglandine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Info

Publication number
DE2258668C3
DE2258668C3 DE19722258668 DE2258668A DE2258668C3 DE 2258668 C3 DE2258668 C3 DE 2258668C3 DE 19722258668 DE19722258668 DE 19722258668 DE 2258668 A DE2258668 A DE 2258668A DE 2258668 C3 DE2258668 C3 DE 2258668C3
Authority
DE
Germany
Prior art keywords
compound
hydroxy
solution
ecm
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19722258668
Other languages
German (de)
English (en)
Other versions
DE2258668A1 (de
DE2258668B2 (de
Inventor
John H. Palo Alto Calif. Fried
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Palo Alto LLC
Original Assignee
Roche Palo Alto LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Palo Alto LLC filed Critical Roche Palo Alto LLC
Publication of DE2258668A1 publication Critical patent/DE2258668A1/de
Publication of DE2258668B2 publication Critical patent/DE2258668B2/de
Application granted granted Critical
Publication of DE2258668C3 publication Critical patent/DE2258668C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/516—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of nitrogen-containing compounds to >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08—Copper compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19722258668 1971-12-03 1972-11-30 Neue Prostaglandine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel Expired DE2258668C3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20476971A 1971-12-03 1971-12-03
US30641472A 1972-11-14 1972-11-14

Publications (3)

Publication Number Publication Date
DE2258668A1 DE2258668A1 (de) 1973-08-02
DE2258668B2 DE2258668B2 (de) 1980-11-27
DE2258668C3 true DE2258668C3 (de) 1981-08-06

Family

ID=26899786

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722258668 Expired DE2258668C3 (de) 1971-12-03 1972-11-30 Neue Prostaglandine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Country Status (8)

Country Link
JP (1) JPS4864053A (enExample)
CH (3) CH594623A5 (enExample)
DE (1) DE2258668C3 (enExample)
ES (1) ES409251A1 (enExample)
GB (1) GB1413831A (enExample)
HK (1) HK75176A (enExample)
MY (1) MY7700076A (enExample)
NL (1) NL7216377A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873598A (en) * 1973-07-06 1975-03-25 Syntex Inc 4,5,10,13 prostatetraenoic acid derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754114A (fr) * 1969-07-29 1971-01-29 Upjohn Co Nouveaux composes de la classe des prostaglandines et leur procede de preparation
CA927392A (en) * 1970-03-09 1973-05-29 Philip F. Beal, Iii Cyclopentane derivatives
CA959485A (en) * 1970-05-04 1974-12-17 Gordon L. Bundy 15-alkyl prostaglandins

Also Published As

Publication number Publication date
CH594623A5 (enExample) 1978-01-13
HK75176A (en) 1976-12-10
CH590836A5 (enExample) 1977-08-31
MY7700076A (en) 1977-12-31
CH589620A5 (enExample) 1977-07-15
DE2258668A1 (de) 1973-08-02
NL7216377A (enExample) 1973-06-05
JPS4864053A (enExample) 1973-09-05
DE2258668B2 (de) 1980-11-27
ES409251A1 (es) 1976-05-16
GB1413831A (en) 1975-11-12

Similar Documents

Publication Publication Date Title
DE69607704T2 (de) Neue selektive inhibitoren viraler oder bakterieller neuraminidasen
DE2437388A1 (de) Prostansaeurederivate
DE2627910A1 (de) 16-phenoxy- und 16-substituierte phenoxyprostatriensaeurederivate und verfahren zu ihrer herstellung
DE2355731C3 (de) Derivate von w -nor-Prostaglandinen- E2IUId -F2 a , Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Zusammensetzungen Pfizer Ine, New York, N.Y. (YStA.)
DE2355540C2 (de) 16-Phenoxy-ω-tetranorprostaglandinderivate
DE2517771A1 (de) Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung
DE2627704C2 (de) Bicycloheptenverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CH618968A5 (enExample)
DE2234709C2 (de) Prostanoesäurederivate und Verfahren zu deren Herstellung
DE2638827A1 (de) Neue 11-deoxy-prostaglandine e, f tief alpha und f tief beta
DE2258668C3 (de) Neue Prostaglandine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2510818A1 (de) 15-cyclobutyl-prostaglandin-analoge
DE2743283A1 (de) Neue prostacyclin-analoga
DE2705613C3 (de) Bicycloheptylderivate von Prostagiandinen und Verfahren zu deren Herstellung sowie Zwischenprodukte zu deren Herstellung und Arzneimittel, welche die Bicycloheptylderivate enthalten
DE2319017B2 (de) Verfahren zur Herstellung von Prostaglandinen der Eins-Reihe
DE2347172A1 (de) Prostaglandin e tief 1-synthese
CH640847A5 (en) Process for preparing analogues of 5,6-dihydroprostacyclin
DE2611788A1 (de) Fluorprostaglandine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DE2628364A1 (de) Dl- und 8r-9-fluorprostadiensaeurederivate und verfahren zu deren herstellung
DE2711950A1 (de) Neue lactone, die sich vom cyclopentanol herleiten, deren herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen
DE68905562T2 (de) Verfahren zur Herstellung des (+)-Isomers von Cloprostenol.
DE2429354A1 (de) Prosta-5-cis,11,13-trans-triensaeuren und deren derivate
DE2355042A1 (de) Neue prostaglandinanaloge und verfahren zu deren herstellung
DE2716075A1 (de) Neue zwischenprodukte und verfahren zur herstellung von thromboxan-analoga
DE2542686A1 (de) 2a,2b-dihomo-15-methyl- und -15- aethyl-pgf-und pge-verbindungen und verfahren zu deren herstellung

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee